{"id":112917,"date":"2024-04-02T11:39:37","date_gmt":"2024-04-02T06:09:37","guid":{"rendered":"http:\/\/finservwealth.com\/french-pharma-major-sanofi-plans-first-in-class-drug-launches-in-india\/"},"modified":"2024-04-02T11:39:37","modified_gmt":"2024-04-02T06:09:37","slug":"french-pharma-major-sanofi-plans-first-in-class-drug-launches-in-india","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/french-pharma-major-sanofi-plans-first-in-class-drug-launches-in-india\/","title":{"rendered":"French pharma major Sanofi plans first-in-class drug launches in India"},"content":{"rendered":"<p> To bolster its market presence, Sanofi has entered into distribution agreements with prominent pharmaceutical companies such as Cipla, Dr Reddy\u00e2\u20ac\u2122s, and Emcure Pharma<\/p><div id=\"finse-832897069\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/health\/french-pharma-major-sanofi-plans-first-in-class-drug-launchesindia_17512671.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0To bolster its market presence, Sanofi has entered into distribution agreements with prominent pharmaceutical companies such as Cipla, Dr Reddy\u00e2\u20ac\u2122s, and Emcure Pharma To bolster its market presence, Sanofi has entered into distribution agreements with prominent pharmaceutical companies such as Cipla, Dr Reddy\u00e2\u20ac\u2122s, and Emcure Pharma\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/health\/french-pharma-major-sanofi-plans-first-in-class-drug-launchesindia_17512671.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> To bolster its market presence, Sanofi has entered into distribution agreements with prominent pharmaceutical companies such as Cipla, Dr Reddy\u00e2\u20ac\u2122s, and Emcure Pharma<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/health\/french-pharma-major-sanofi-plans-first-in-class-drug-launchesindia_17512671.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0To bolster its market presence, Sanofi has entered into distribution agreements with prominent pharmaceutical companies such as Cipla, Dr Reddy\u00e2\u20ac\u2122s, and Emcure Pharma To bolster its market presence, Sanofi has entered into distribution agreements with prominent pharmaceutical companies such as Cipla, Dr Reddy\u00e2\u20ac\u2122s, and Emcure Pharma\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/health\/french-pharma-major-sanofi-plans-first-in-class-drug-launchesindia_17512671.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> To bolster its market presence, Sanofi has entered into distribution agreements with prominent pharmaceutical companies such as Cipla, Dr Reddy\u00e2\u20ac\u2122s, and Emcure Pharma<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-112917","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2023\/200x200\/R\/Rodolfo-Hrosz-Sanofi-India-MD_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/112917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=112917"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/112917\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=112917"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=112917"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=112917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}